A serum-free adipose-conditioned medium delays stem cell senescence and maintains tissue homeostasis via IL-6/STAT3

Jing Li1, Longzhu Song1, Dongzi Song1

  • 1Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

PubMed
Abstract

Insights

A novel serum-free adipose-conditioned medium (SF-ACM) effectively combats cellular senescence in stem cells and fibroblasts. This SF-ACM formulation shows promise for regenerative medicine and anti-aging strategies by preserving tissue homeostasis.

Area of Science:

  • Gerontology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Cellular senescence and stem cell exhaustion are key aging hallmarks.
  • Mesenchymal stem cells (MSCs) are vital for tissue regeneration but susceptible to senescence, impairing their therapeutic potential.
  • Inhibiting MSC senescence is crucial for effective anti-aging and regenerative therapies.

Purpose of the Study:

  • To develop and evaluate a novel serum-free adipose-conditioned medium (SF-ACM) for its anti-aging properties.
  • To assess SF-ACM's efficacy in mitigating senescence in human adipose-derived stem cells (ADSCs) and dermal fibroblasts (HDFs).
  • To investigate SF-ACM's effects on aging phenotypes in vivo and elucidate its underlying mechanisms.

Main Methods:

  • SF-ACM was derived from human adipose explants.
  • In vitro studies used oxidative stress- and replicative senescence models of ADSCs and HDFs, assessing proliferation, senescence markers, migration, and differentiation.
  • In vivo studies administered SF-ACM to young and aged mice to evaluate aging phenotypes and safety.

Main Results:

  • SF-ACM significantly reduced senescence markers (p16, p21, p53, SA-β-gal) and enhanced proliferation, migration, and differentiation in ADSCs.
  • SF-ACM decreased senescence and fibrosis markers in HDFs.
  • In aged mice, SF-ACM improved skin, adipose tissue, and skeletal muscle aging phenotypes, linked to IL-6/STAT3 pathway suppression.

Conclusions:

  • SF-ACM is a novel, xenogeneic-free formulation that delays cellular senescence and maintains tissue homeostasis.
  • This SF-ACM formulation demonstrates potential as a safe and effective strategy for suppressing cellular aging.
  • Findings support SF-ACM's translational promise for regenerative medicine and anti-aging interventions by restoring stem cell function and ameliorating tissue aging.